World-class Care in a Community Setting
In June, The Johns Hopkins Kimmel Cancer Center’s Breast Center at Green Spring Station opened its doors to a brand new space in its existing… Read More »World-class Care in a Community Setting
Issues & Perspectives
Helping Breast Cancer Survivors Reach Their Weight-Loss Goals
Numerous studies have shown that even a modest amount of weight loss can improve a variety of health-related metrics and quality of life for those… Read More »Helping Breast Cancer Survivors Reach Their Weight-Loss Goals
Not On My Watch – Dr. Arjun Gupta
Dr Arjun Gupta discusses a 'Cancer Care Chronicles' essay he published in JAMA Oncology, titled ''Not On My Watch.'' In the essay, he shares his… Read More »Not On My Watch – Dr. Arjun Gupta
Platz Named Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention
A national publication on cancer causes, prevention, detection and survivorship will have a Johns Hopkins cancer epidemiologist at the helm for 2019. Elizabeth Platz, M.P.H.,… Read More »Platz Named Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention
Moving for Melanoma of Delaware Supports Melanoma Research at Johns Hopkins
Members of the Johns Hopkins Melanoma Program participated in an annual 5K walk/run event and received funds raised by the event during a visit in… Read More »Moving for Melanoma of Delaware Supports Melanoma Research at Johns Hopkins
Pancreatic Cancer Matters: Right Treatment at the Right Time
Our collaborative team of scientists, physicians and allied health workers at the Johns Hopkins Kimmel Cancer Center specialize in translating science learned in the laboratory… Read More »Pancreatic Cancer Matters: Right Treatment at the Right Time
The Future of Pancreatic Cancer Treatments
Just eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances… Read More »The Future of Pancreatic Cancer Treatments
Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers
A guideline on guide the clinical practice of managing adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy continues to draw readers nearly… Read More »Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers
Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important… Read More »Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Three Minutes with Oncologist Michael Carducci
Michael Carducci, M.D., is the associate cancer center director for clinical research within the Johns Hopkins Kimmel Cancer Center and the regional research director for… Read More »Three Minutes with Oncologist Michael Carducci